A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.47 USD -1.17% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amneal Intermediate Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Cash & Cash Equivalents
$91.5m
CAGR 3-Years
-36%
CAGR 5-Years
-16%
CAGR 10-Years
-7%
Johnson & Johnson
NYSE:JNJ
Cash & Cash Equivalents
$8.2B
CAGR 3-Years
20%
CAGR 5-Years
15%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Cash & Cash Equivalents
$6.3B
CAGR 3-Years
-17%
CAGR 5-Years
-26%
CAGR 10-Years
4%
Pfizer Inc
NYSE:PFE
Cash & Cash Equivalents
$1.1B
CAGR 3-Years
-19%
CAGR 5-Years
-18%
CAGR 10-Years
-8%
Merck & Co Inc
NYSE:MRK
Cash & Cash Equivalents
$11.3B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Cash & Cash Equivalents
$3.2B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
-2%

See Also

What is Amneal Intermediate Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
91.5m USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Cash & Cash Equivalents amounts to 91.5m USD.

What is Amneal Intermediate Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-7%

Over the last year, the Cash & Cash Equivalents growth was 252%. The average annual Cash & Cash Equivalents growth rates for Amneal Intermediate Inc have been -36% over the past three years , -16% over the past five years , and -7% over the past ten years .

Back to Top